Usually, when you have reached your weight loss goal, you will be put on the maintenance dose of your medication
Additionally, factors related to clinical treatmentsuch as the type of GLP-1RAs, dosage, combination therapy, and duration of treatmenthave exhibited diverse impacts with respect to cancer risk
At the same time, large CDMOs (e.g
Immunogenicity thus demands rigorous evaluation for clinical use
Originally developed for diabetes management, these therapies have demonstrated significant effectiveness in weight management and are reshaping conversations around obesity treatment, chronic disease prevention, and long-term healthcare costs
Here's a breakdown: 1